NCT06143904View on ClinicalTrials.gov

A Study to Evaluate Absolute Bioavailability, Absorption, Metabolism, and Excretion of Genz-112638 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 3, 2009

Primary Completion Date

July 5, 2009

Study Completion Date

July 5, 2009

Conditions
Gaucher's Disease Type I
Interventions
DRUG

Genz-112638

Pharmaceutical form:Solution-Route of administration:IV

DRUG

Genz-112638

Pharmaceutical form:Capsule-Route of administration:Oral

DRUG

[14C]-Genz-112638

Pharmaceutical form:Solution-Route of administration:Oral

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT06143904 - A Study to Evaluate Absolute Bioavailability, Absorption, Metabolism, and Excretion of Genz-112638 in Healthy Male Participants | Biotech Hunter | Biotech Hunter